CoChat

Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

BACKGROUND The global burden of non-alcoholic fatty liver disease (NAFLD) parallels the increase in obesity rates across the world. Although overweight and obesity status are thought to be an effective indicator for NAFLD screening, the exact prevalence of NAFLD in this population remains unknown. We aimed to report the prevalence of NAFLD, non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH) in the overweight and obese population. METHODS In this systematic review and meta-analysis, we searched Medline and Embase from database inception until March 6, 2022, using search terms including but not limited to "non-alcoholic fatty liver disease", "overweight", "obesity", and "prevalence". Cross-sectional and longitudinal observational studies published after Jan 1, 2000, written in or translated into English were eligible for inclusion; paediatric studies were excluded. Articles were included if the number of NAFLD, NAFL, or NASH events in an overweight and obese population could be extracted. Summary data were extracted from published reports. The primary outcomes were the prevalence of NAFLD, NAFL, and NASH in an overweight and obese population and the prevalence of fibrosis in individuals who were overweight or obese and who had NAFLD. A meta-analysis of proportions was done with the generalised linear mixed model. This study is registered with PROSPERO (CRD42022344526). FINDINGS The search identified 7389 articles. 151 studies met the inclusion criteria a…

Overview

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(22)00317-x

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 66 references

Cited by

See all 869

Metadata

Authors
Quek, J., Chan, K. E., Wong, Z. Y., Tan, C., Tan, B., Lim, W. H., Tan, D. J. H., Tang, A. S. P., Tay, P., Xiao, J., Yong, J. N., Zeng, R. W., Chew, N. W. S., Nah, B., Kulkarni, A., Siddiqui, M. S., Dan, Y. Y., Wong, V. W.-S., Sanyal, A. J., Noureddin, M., Muthiah, M., & Ng, C. H.
Affiliations
  • National University of Singapore (SG)
  • Nottingham University Hospitals NHS Trust (GB)
  • Asian Institute of Gastroenterology (IN)
  • Virginia Commonwealth University (US)
  • Chinese University of Hong Kong (HK)
  • Houston Institute for Clinical Research (US)
Corresponding author
Muthiah, Mark
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2023-01
Volume
8
Issue
1
Pages
20-30
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W4309348832
Cited by
749
References
66
Citations by year
2026: 202 · 2025: 252 · 2024: 205 · 2023: 86
FWCI
21.69
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet. Gastroenterology & hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, obesity, overweight, prevalence, liver fibrosis, global burden of disease, NAFLD screening
MeSH terms
Child, Cross-Sectional Studies, Fibrosis, Humans, Obesity, Overweight, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/s2468-1253(22)00317-x
The paper
Quek, J., Chan, K. E., Wong, Z. Y., Tan, C., Tan, B., Lim, W. H., Tan, D. J. H., Tang, A. S. P., Tay, P., Xiao, J., Yong, J. N., Zeng, R. W., Chew, N. W. S., Nah, B., Kulkarni, A., Siddiqui, M. S., Dan, Y. Y., Wong, V. W.-S., Sanyal, A. J., . . . Ng, C. H. (2023). Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(22)00317-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.